[1] |
赵桂华, 王洪法, 仲维霞, 等.新疆喀什地区黑热病暴发的危险因素分析[J].中国人兽共患病学报, 2015, 31(6): 592-596.
|
[2] |
敬保迁, 张仁刚, 邓世山, 等.杜氏利什曼原虫前鞭毛体与无鞭毛体的比较蛋白质组学研究[J].中国寄生虫学与寄生虫病杂志, 2009, 27(2): 102-106.
|
[3] |
da Fonseca Pires S, Fialho LC Jr, Silva SO, et al.Identification of virulence factors in Leishmania infantum strains by a proteomic approach.[J].J Proteome Res, 2014, 13(4): 1860-1872.
|
[4] |
Henard CA, Carlsen ED, Hay C, et al.Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence[J].PLoS Negl Trop Dis, 2014, 8(7): e3000.
|
[5] |
Castro H, Teixeira F, Romao S, et al. Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity[J].PLoS Pathog, 2011, 7(10): e1002325.
|
[6] |
Teixeira F, Castro H, Cruz T, et al. Mitochondrial peroxiredoxin functions as crucial chaperone reservoir in Leishmania infantum[J].Proc Natl Acad Sci USA, 2015, 112(7): E616-E624.
|
[7] |
Garami A.Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability[J].EMBO J, 2001, 20(14): 3657-3666.
|
[8] |
Mao W, Daligaux P, Lazar N, et al. Biochemical analysis of leishmanial and human GDP-mannose pyrophosphorylases and selection of inhibitors as new leads[J].Sci Rep, 2017, 7(1): 751.
|
[9] |
张仁刚, 张洁, 敬保迁.不同种株利什曼原虫前鞭毛体体外向无鞭毛体转化的研究[J].四川动物, 2009, 28(4), 488-492.
|
[10] |
Espitia CM, Saldarriaga OA, Travi BL, et al. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes[J].BMC Immunol, 2014, 15: 38.
|
[11] |
Mougneau E, Bihl F, Glaichenhaus N.Cell biology and immunology of Leishmania.[J].Immunol Rev, 2011, 240(1): 286-296.
|
[12] |
Charmoy M, Hurrell BP, Romano A, et al. The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice[J].Eur J Immuno, 2016, 46(4): 897-911.
|
[13] |
Curry AJ, Kaye PM.Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani[J].Infect Immun, 1992, 60(10): 4422-4426.
|
[14] |
Terrazas C, Varikuti S, Kimble J, et al. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani[J].FASEB J, 2016, 30(3): 1135-1143.
|
[15] |
Lopez Kostka S, Dinges S, Griewank K, et al. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice[J].J Immunol, 2009, 182(5): 3039-3046.
|
[16] |
Gonzalez-Lombana C, Gimblet C, Bacellar O, et al. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection[J].PLoS Pathog, 2013, 9(3): e1003243.
|
[17] |
王健, 关望, 张仁刚, 等.杜氏利什曼原虫无鞭毛体表达抗原的Western Blot和MALDI-TO F/TOF分析[J].中国病原生物学杂志, 2014, 9(2): 135-139.
|
[18] |
Bhattacharya P, Ghosh S, Ejazi SA, et al. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T cells correlates with parasite load in Indian Kala-azar patients infected with Leishmania donovani[J].PLoS Negl Trop Dis, 2016, 10(2): e0004422.
|
[19] |
Girard-Madoux MJH, Kautz-Neu K, Lorenz B, et al. IL-10 signaling in dendritic cells attenuates anti-Leishmania major immunity without affecting protective memory responses[J].J Invest Dermatol, 2015, 135(11): 2890-2894.
|
[20] |
Kamhawi S, Oliveira F, Vaenzuela JG.Using humans to make a human leishmaniasis vaccine[J].Sci Transl Med, 2014,6(234): 234fs18.
|
[21] |
Carson C, Antoniou M, Ruiz-Argüello MB, et al. A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis[J].Vaccine, 2009, 27(7): 1080-1086.
|
[22] |
Daifalla NS, Bayih AG, Gedamu L.Differential immune response against recombinant Leishmania donovani peroxidoxin 1 and peroxidoxin 2 proteins in BALB/c mice[J].J Immunol Res, 2015, 2015: 1-11.
|
[23] |
Núñez MC, Laurenti MD, Gómez-Sebastián S, et al. Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania[J].PLoS One, 2012, 7(12): e51181.
|
[24] |
Rodríguez-Cortés A, Ojeda A, López-Fuertes L, et al. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge[J].Vaccine, 2007, 25(46): 7962-7971.
|
[25] |
敬昊东, 敬保迁.婴儿利什曼原虫细胞免疫优势抗原预测[J].川北医学院学报, 2016, 31(3): 310-314, 335.
|